PortViewPortView
Scienture logo

Scienture (SCNX) Stock Analysis

NASDAQHealthcareMedical - Pharmaceuticals

$0.37+0.98%
1-year price historyRange $0.24 – $2.60
52-week range$0.37
$0.24$2.60

What Scienture does

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.

Key metrics

Market cap
$15.10M
P/E (TTM)
-0.15
EPS (TTM)
$-2.51
Beta
3.96
Dividend yield
0.00%
Revenue / share
$0.02
50-day avg
$0.39
200-day avg
$0.44
52-week high
$2.60
52-week low
$0.24
CEO
Shankar Hariharan

ETFs linked to SCNX

Broad-market and Healthcare sector ETFs an investor holding Scienture is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SCNX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SCNX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Scienture?
Scienture trades under the ticker SCNX on NASDAQ.
Which exchange is SCNX listed on?
SCNX is listed on NASDAQ.
What sector does Scienture operate in?
Scienture is classified in the Healthcare sector (Medical - Pharmaceuticals industry).
How can PortView help analyze SCNX in a portfolio?
PortView shows SCNX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.